The effects of dietary supplementation with fish oil in patients with psoriasis

SUMMARY Ten patients with psoriasis resistant to conventional topical treatment were given dietary supplements of fish oil, providing approximately 12 g of eicosapentaenoic acid daily for a period of at least 6 weeks. In eight patients there was a modest improvement in their psoriasis, the principal...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of dermatology (1951) 1987-11, Vol.117 (5), p.599-606
Hauptverfasser: MAURICE, P.D.L., ALLEN, B.R., BARKLEY, A.S.J., COCKBILL, S.R., STAMMERS, J., BATHER, P.C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 606
container_issue 5
container_start_page 599
container_title British journal of dermatology (1951)
container_volume 117
creator MAURICE, P.D.L.
ALLEN, B.R.
BARKLEY, A.S.J.
COCKBILL, S.R.
STAMMERS, J.
BATHER, P.C.
description SUMMARY Ten patients with psoriasis resistant to conventional topical treatment were given dietary supplements of fish oil, providing approximately 12 g of eicosapentaenoic acid daily for a period of at least 6 weeks. In eight patients there was a modest improvement in their psoriasis, the principal effects being a diminution of erythema and scaling. The dietary treatment resulted in a substantial inhibition of leukotriene B4 production by the peripheral blood polymorphonuclear leukocytes in vitro. The discrepancy between the high degree of inhibition of leukotriene B4 synthesis and the modest therapeutic effect suggests that leukotriene B4 is not the only mediator involved in the development of the psoriatic lesion. Furthermore, the in vivo cutaneous levels of leukotriene B4 might not have been inhibited to the same extent as the polymorphonuclear leukocyte levels in vitro. Further studies on the use of fish oil supplements, both on their own and in conjunction with other forms of treatment in psoriasis are warranted. It will also be important to determine whether the altered profile of 5‐lipoxygcnase products found in the blood is also seen in the skin.
doi_str_mv 10.1111/j.1365-2133.1987.tb07492.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77844118</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77844118</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4369-3ca3ef2d35987fc225e3565485a84bf426a96933083a90343a137057d84a41b53</originalsourceid><addsrcrecordid>eNqVkE9v1DAQxS0EKkvhIyBZCHFLsDP-ywEJulAoFVVREdwsb9bWeskmIZNVt98erxLtHV9G8nvzZuZHyCvOSp7f223JQcmi4gAlt0aX44ppYavy8IgsTtJjsmCM6YJZBU_JM8QtYxyYZGfkDJSxSpsFubnbBBpiDPWItIt0ncLohweK-75vwi60ox9T19L7NG5oTLihXWpoammf_7OKk9JjNySPCZ-TJ9E3GF7M9Zz8_Pzp7uJLcX1z-fXiw3VRC1C2gNpDiNUaZF4_1lUlA0glhZHeiFUUlfJWWQBmwFsGAjwHzaReG-EFX0k4J2-m3H7o_u4Djm6XsA5N49vQ7dFpbYTg3GTju8lYDx3iEKLrh7TLJzrO3JGm27ojMndE5o403UzTHXLzy3nKfrUL61PrjC_rr2fdY-2bOPi2TniyabBCGpFt7yfbfWrCw38s4D5eLaW1OaCYAhKO4XAK8MMfpzRo6X59v3RXyx-33_Ty1v2Gf7BMn_g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77844118</pqid></control><display><type>article</type><title>The effects of dietary supplementation with fish oil in patients with psoriasis</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>MAURICE, P.D.L. ; ALLEN, B.R. ; BARKLEY, A.S.J. ; COCKBILL, S.R. ; STAMMERS, J. ; BATHER, P.C.</creator><creatorcontrib>MAURICE, P.D.L. ; ALLEN, B.R. ; BARKLEY, A.S.J. ; COCKBILL, S.R. ; STAMMERS, J. ; BATHER, P.C.</creatorcontrib><description>SUMMARY Ten patients with psoriasis resistant to conventional topical treatment were given dietary supplements of fish oil, providing approximately 12 g of eicosapentaenoic acid daily for a period of at least 6 weeks. In eight patients there was a modest improvement in their psoriasis, the principal effects being a diminution of erythema and scaling. The dietary treatment resulted in a substantial inhibition of leukotriene B4 production by the peripheral blood polymorphonuclear leukocytes in vitro. The discrepancy between the high degree of inhibition of leukotriene B4 synthesis and the modest therapeutic effect suggests that leukotriene B4 is not the only mediator involved in the development of the psoriatic lesion. Furthermore, the in vivo cutaneous levels of leukotriene B4 might not have been inhibited to the same extent as the polymorphonuclear leukocyte levels in vitro. Further studies on the use of fish oil supplements, both on their own and in conjunction with other forms of treatment in psoriasis are warranted. It will also be important to determine whether the altered profile of 5‐lipoxygcnase products found in the blood is also seen in the skin.</description><identifier>ISSN: 0007-0963</identifier><identifier>EISSN: 1365-2133</identifier><identifier>DOI: 10.1111/j.1365-2133.1987.tb07492.x</identifier><identifier>PMID: 3689678</identifier><identifier>CODEN: BJDEAZ</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Adult ; Arachidonate 5-Lipoxygenase - blood ; Biological and medical sciences ; Blood Platelets - metabolism ; Chromatography, High Pressure Liquid ; Dermatology ; Dietary Fats, Unsaturated - therapeutic use ; Docosahexaenoic Acids ; Drug Combinations ; Eicosapentaenoic Acid ; Fatty Acids - blood ; Fatty Acids, Unsaturated - therapeutic use ; Female ; Fish Oils - therapeutic use ; Humans ; Male ; Medical sciences ; Middle Aged ; Neutrophils - enzymology ; Psoriasis - blood ; Psoriasis - diet therapy ; Psoriasis. Parapsoriasis. Lichen ; Thromboxane B2 - blood</subject><ispartof>British journal of dermatology (1951), 1987-11, Vol.117 (5), p.599-606</ispartof><rights>1988 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4369-3ca3ef2d35987fc225e3565485a84bf426a96933083a90343a137057d84a41b53</citedby><cites>FETCH-LOGICAL-c4369-3ca3ef2d35987fc225e3565485a84bf426a96933083a90343a137057d84a41b53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1365-2133.1987.tb07492.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1365-2133.1987.tb07492.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=7394584$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3689678$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MAURICE, P.D.L.</creatorcontrib><creatorcontrib>ALLEN, B.R.</creatorcontrib><creatorcontrib>BARKLEY, A.S.J.</creatorcontrib><creatorcontrib>COCKBILL, S.R.</creatorcontrib><creatorcontrib>STAMMERS, J.</creatorcontrib><creatorcontrib>BATHER, P.C.</creatorcontrib><title>The effects of dietary supplementation with fish oil in patients with psoriasis</title><title>British journal of dermatology (1951)</title><addtitle>Br J Dermatol</addtitle><description>SUMMARY Ten patients with psoriasis resistant to conventional topical treatment were given dietary supplements of fish oil, providing approximately 12 g of eicosapentaenoic acid daily for a period of at least 6 weeks. In eight patients there was a modest improvement in their psoriasis, the principal effects being a diminution of erythema and scaling. The dietary treatment resulted in a substantial inhibition of leukotriene B4 production by the peripheral blood polymorphonuclear leukocytes in vitro. The discrepancy between the high degree of inhibition of leukotriene B4 synthesis and the modest therapeutic effect suggests that leukotriene B4 is not the only mediator involved in the development of the psoriatic lesion. Furthermore, the in vivo cutaneous levels of leukotriene B4 might not have been inhibited to the same extent as the polymorphonuclear leukocyte levels in vitro. Further studies on the use of fish oil supplements, both on their own and in conjunction with other forms of treatment in psoriasis are warranted. It will also be important to determine whether the altered profile of 5‐lipoxygcnase products found in the blood is also seen in the skin.</description><subject>Adult</subject><subject>Arachidonate 5-Lipoxygenase - blood</subject><subject>Biological and medical sciences</subject><subject>Blood Platelets - metabolism</subject><subject>Chromatography, High Pressure Liquid</subject><subject>Dermatology</subject><subject>Dietary Fats, Unsaturated - therapeutic use</subject><subject>Docosahexaenoic Acids</subject><subject>Drug Combinations</subject><subject>Eicosapentaenoic Acid</subject><subject>Fatty Acids - blood</subject><subject>Fatty Acids, Unsaturated - therapeutic use</subject><subject>Female</subject><subject>Fish Oils - therapeutic use</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neutrophils - enzymology</subject><subject>Psoriasis - blood</subject><subject>Psoriasis - diet therapy</subject><subject>Psoriasis. Parapsoriasis. Lichen</subject><subject>Thromboxane B2 - blood</subject><issn>0007-0963</issn><issn>1365-2133</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1987</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkE9v1DAQxS0EKkvhIyBZCHFLsDP-ywEJulAoFVVREdwsb9bWeskmIZNVt98erxLtHV9G8nvzZuZHyCvOSp7f223JQcmi4gAlt0aX44ppYavy8IgsTtJjsmCM6YJZBU_JM8QtYxyYZGfkDJSxSpsFubnbBBpiDPWItIt0ncLohweK-75vwi60ox9T19L7NG5oTLihXWpoammf_7OKk9JjNySPCZ-TJ9E3GF7M9Zz8_Pzp7uJLcX1z-fXiw3VRC1C2gNpDiNUaZF4_1lUlA0glhZHeiFUUlfJWWQBmwFsGAjwHzaReG-EFX0k4J2-m3H7o_u4Djm6XsA5N49vQ7dFpbYTg3GTju8lYDx3iEKLrh7TLJzrO3JGm27ojMndE5o403UzTHXLzy3nKfrUL61PrjC_rr2fdY-2bOPi2TniyabBCGpFt7yfbfWrCw38s4D5eLaW1OaCYAhKO4XAK8MMfpzRo6X59v3RXyx-33_Ty1v2Gf7BMn_g</recordid><startdate>198711</startdate><enddate>198711</enddate><creator>MAURICE, P.D.L.</creator><creator>ALLEN, B.R.</creator><creator>BARKLEY, A.S.J.</creator><creator>COCKBILL, S.R.</creator><creator>STAMMERS, J.</creator><creator>BATHER, P.C.</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198711</creationdate><title>The effects of dietary supplementation with fish oil in patients with psoriasis</title><author>MAURICE, P.D.L. ; ALLEN, B.R. ; BARKLEY, A.S.J. ; COCKBILL, S.R. ; STAMMERS, J. ; BATHER, P.C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4369-3ca3ef2d35987fc225e3565485a84bf426a96933083a90343a137057d84a41b53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1987</creationdate><topic>Adult</topic><topic>Arachidonate 5-Lipoxygenase - blood</topic><topic>Biological and medical sciences</topic><topic>Blood Platelets - metabolism</topic><topic>Chromatography, High Pressure Liquid</topic><topic>Dermatology</topic><topic>Dietary Fats, Unsaturated - therapeutic use</topic><topic>Docosahexaenoic Acids</topic><topic>Drug Combinations</topic><topic>Eicosapentaenoic Acid</topic><topic>Fatty Acids - blood</topic><topic>Fatty Acids, Unsaturated - therapeutic use</topic><topic>Female</topic><topic>Fish Oils - therapeutic use</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neutrophils - enzymology</topic><topic>Psoriasis - blood</topic><topic>Psoriasis - diet therapy</topic><topic>Psoriasis. Parapsoriasis. Lichen</topic><topic>Thromboxane B2 - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MAURICE, P.D.L.</creatorcontrib><creatorcontrib>ALLEN, B.R.</creatorcontrib><creatorcontrib>BARKLEY, A.S.J.</creatorcontrib><creatorcontrib>COCKBILL, S.R.</creatorcontrib><creatorcontrib>STAMMERS, J.</creatorcontrib><creatorcontrib>BATHER, P.C.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>British journal of dermatology (1951)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MAURICE, P.D.L.</au><au>ALLEN, B.R.</au><au>BARKLEY, A.S.J.</au><au>COCKBILL, S.R.</au><au>STAMMERS, J.</au><au>BATHER, P.C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The effects of dietary supplementation with fish oil in patients with psoriasis</atitle><jtitle>British journal of dermatology (1951)</jtitle><addtitle>Br J Dermatol</addtitle><date>1987-11</date><risdate>1987</risdate><volume>117</volume><issue>5</issue><spage>599</spage><epage>606</epage><pages>599-606</pages><issn>0007-0963</issn><eissn>1365-2133</eissn><coden>BJDEAZ</coden><abstract>SUMMARY Ten patients with psoriasis resistant to conventional topical treatment were given dietary supplements of fish oil, providing approximately 12 g of eicosapentaenoic acid daily for a period of at least 6 weeks. In eight patients there was a modest improvement in their psoriasis, the principal effects being a diminution of erythema and scaling. The dietary treatment resulted in a substantial inhibition of leukotriene B4 production by the peripheral blood polymorphonuclear leukocytes in vitro. The discrepancy between the high degree of inhibition of leukotriene B4 synthesis and the modest therapeutic effect suggests that leukotriene B4 is not the only mediator involved in the development of the psoriatic lesion. Furthermore, the in vivo cutaneous levels of leukotriene B4 might not have been inhibited to the same extent as the polymorphonuclear leukocyte levels in vitro. Further studies on the use of fish oil supplements, both on their own and in conjunction with other forms of treatment in psoriasis are warranted. It will also be important to determine whether the altered profile of 5‐lipoxygcnase products found in the blood is also seen in the skin.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>3689678</pmid><doi>10.1111/j.1365-2133.1987.tb07492.x</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0007-0963
ispartof British journal of dermatology (1951), 1987-11, Vol.117 (5), p.599-606
issn 0007-0963
1365-2133
language eng
recordid cdi_proquest_miscellaneous_77844118
source MEDLINE; Wiley Online Library All Journals
subjects Adult
Arachidonate 5-Lipoxygenase - blood
Biological and medical sciences
Blood Platelets - metabolism
Chromatography, High Pressure Liquid
Dermatology
Dietary Fats, Unsaturated - therapeutic use
Docosahexaenoic Acids
Drug Combinations
Eicosapentaenoic Acid
Fatty Acids - blood
Fatty Acids, Unsaturated - therapeutic use
Female
Fish Oils - therapeutic use
Humans
Male
Medical sciences
Middle Aged
Neutrophils - enzymology
Psoriasis - blood
Psoriasis - diet therapy
Psoriasis. Parapsoriasis. Lichen
Thromboxane B2 - blood
title The effects of dietary supplementation with fish oil in patients with psoriasis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T13%3A08%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20effects%20of%20dietary%20supplementation%20with%20fish%20oil%20in%20patients%20with%20psoriasis&rft.jtitle=British%20journal%20of%20dermatology%20(1951)&rft.au=MAURICE,%20P.D.L.&rft.date=1987-11&rft.volume=117&rft.issue=5&rft.spage=599&rft.epage=606&rft.pages=599-606&rft.issn=0007-0963&rft.eissn=1365-2133&rft.coden=BJDEAZ&rft_id=info:doi/10.1111/j.1365-2133.1987.tb07492.x&rft_dat=%3Cproquest_cross%3E77844118%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77844118&rft_id=info:pmid/3689678&rfr_iscdi=true